[
  {
    "title": "蒙脱石散、诺氟沙星突然爆火，概念股掀涨停潮 华纳药厂订单增加 专家：别乱吃",
    "href": "http://stock.jrj.com.cn/2023/01/04102037257559.shtml",
    "datetime": "2023-01-04 10:20:58",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：监事金焰减持完毕 累计减持66.0356万股",
    "href": "http://stock.jrj.com.cn/2022/12/22175537231977.shtml",
    "datetime": "2022-12-22 17:55:20",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：减持数过半 监事金焰累计减持0.61%股份",
    "href": "http://stock.jrj.com.cn/2022/12/15164437215344.shtml",
    "datetime": "2022-12-15 16:44:59",
    "code": "688799"
  },
  {
    "title": "A股异动 | 华纳药厂(688799.SH)高开8.42% 手性药物公司化学原料药右布洛芬获批上市",
    "href": "http://stock.jrj.com.cn/2022/12/08092837197069.shtml",
    "datetime": "2022-12-08 09:28:35",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：手性药物公司化学原料药右布洛芬获批上市",
    "href": "http://stock.jrj.com.cn/2022/12/07193137196048.shtml",
    "datetime": "2022-12-07 19:31:56",
    "code": "688799"
  },
  {
    "title": "华纳药厂：子公司原料药右布洛芬获得上市申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/12/07193037196004.shtml",
    "datetime": "2022-12-07 19:30:04",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：琥珀酸亚铁片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/12/05171437189137.shtml",
    "datetime": "2022-12-05 17:14:51",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：监事金焰拟减持不超75.9万股",
    "href": "http://stock.jrj.com.cn/2022/11/11171737131804.shtml",
    "datetime": "2022-11-11 17:17:00",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：第三季度净利增18.26%至4032.14万元",
    "href": "http://stock.jrj.com.cn/2022/10/30165537097384.shtml",
    "datetime": "2022-10-30 16:55:51",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：发行可转债申请获上交所受理",
    "href": "http://stock.jrj.com.cn/2022/10/27143737089290.shtml",
    "datetime": "2022-10-27 14:37:57",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：原料药品种替格瑞洛通过药品GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2022/09/16171837000790.shtml",
    "datetime": "2022-09-16 17:18:03",
    "code": "688799"
  },
  {
    "title": "华纳药厂拟发行可转债，募资总额不超过7亿元",
    "href": "http://stock.jrj.com.cn/2022/08/30171636953147.shtml",
    "datetime": "2022-08-30 17:16:09",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：拟发行可转债募资不超7亿元、用于高端制剂产研基地建设项目",
    "href": "http://stock.jrj.com.cn/2022/08/30145236952431.shtml",
    "datetime": "2022-08-30 14:52:09",
    "code": "688799"
  },
  {
    "title": "华纳药厂披露2022年半年报 实现营收5.92亿元",
    "href": "http://stock.jrj.com.cn/2022/08/30091736950888.shtml",
    "datetime": "2022-08-30 09:17:14",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：上半年净利润增21.19%至8382.03万元",
    "href": "http://stock.jrj.com.cn/2022/08/29233536949780.shtml",
    "datetime": "2022-08-29 23:35:32",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：硝普钠获得上市申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/08/04153736870164.shtml",
    "datetime": "2022-08-04 15:37:51",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：拟以合计不超3.8亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/08/01170936859554.shtml",
    "datetime": "2022-08-01 17:09:38",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：枸橼酸铋钾颗粒获药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/07/17154936818432.shtml",
    "datetime": "2022-07-17 15:49:33",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：吗替麦考酚酯胶囊拟中标第七批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2022/07/12181636804183.shtml",
    "datetime": "2022-07-12 18:16:15",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：3533.8万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2022/07/05175136784142.shtml",
    "datetime": "2022-07-05 17:51:31",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：手性药物公司替格瑞洛原料药获批韩国上市",
    "href": "http://stock.jrj.com.cn/2022/06/16161536734731.shtml",
    "datetime": "2022-06-16 16:15:07",
    "code": "688799"
  },
  {
    "title": "华纳药厂（688799）：于线上会议举行投资者关系活动",
    "href": "http://stock.jrj.com.cn/2022/06/02085136699151.shtml",
    "datetime": "2022-06-02 08:51:00",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：收到关于泮托拉唑钠肠溶片的药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/05/29163336687291.shtml",
    "datetime": "2022-05-29 16:33:31",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：2021年年度权益分派10派7元 股权登记日5月17日",
    "href": "http://stock.jrj.com.cn/2022/05/11155236633321.shtml",
    "datetime": "2022-05-11 15:52:16",
    "code": "688799"
  },
  {
    "title": "华纳药厂：子公司原料药获得韩国注册证书",
    "href": "http://stock.jrj.com.cn/2022/05/10134436619073.shtml",
    "datetime": "2022-05-10 13:44:04",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：甘磷酰胆碱原料药获得韩国原料药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/05/09162336606897.shtml",
    "datetime": "2022-05-09 16:23:49",
    "code": "688799"
  },
  {
    "title": "华纳药厂披露2022年一季报 实现营收2.92亿元",
    "href": "http://stock.jrj.com.cn/2022/04/20084536406400.shtml",
    "datetime": "2022-04-20 08:45:57",
    "code": "688799"
  },
  {
    "title": "华纳药厂2022年第一季度净利3409.13万同比增长1.83% 理财产品收益增加",
    "href": "http://stock.jrj.com.cn/2022/04/19211236402254.shtml",
    "datetime": "2022-04-19 21:12:00",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：一季度净利增1.83%至3409.13万元",
    "href": "http://stock.jrj.com.cn/2022/04/19164936399140.shtml",
    "datetime": "2022-04-19 16:49:59",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：维D钙咀嚼片获批上市",
    "href": "http://stock.jrj.com.cn/2022/03/31154236239301.shtml",
    "datetime": "2022-03-31 15:42:52",
    "code": "688799"
  },
  {
    "title": "华纳药厂2021年净利1.61亿同比增长10.85% 董事长黄本东薪酬36.25万",
    "href": "http://stock.jrj.com.cn/2022/03/29145236127853.shtml",
    "datetime": "2022-03-29 14:52:44",
    "code": "688799"
  },
  {
    "title": "华纳药厂2021年市场推广费5.2亿：占营收45% 研发人员平均月薪4750元",
    "href": "http://stock.jrj.com.cn/2022/03/29135236117729.shtml",
    "datetime": "2022-03-29 13:52:36",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)2021年度净利润升10.85%至1.61亿元 拟10派7元",
    "href": "http://stock.jrj.com.cn/2022/03/28213835943991.shtml",
    "datetime": "2022-03-28 21:38:03",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：吗替麦考酚酯胶囊通过仿制药质量和疗效一致性评价",
    "href": "http://stock.jrj.com.cn/2022/03/13155434819047.shtml",
    "datetime": "2022-03-13 15:54:16",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：拟中选广东联盟双氯芬酸等药品集中带量采购",
    "href": "http://stock.jrj.com.cn/2022/03/11180334814822.shtml",
    "datetime": "2022-03-11 18:03:16",
    "code": "688799"
  },
  {
    "title": "华纳药厂2021年净利1.6亿同比增长10.33% 原料药产品销售增加",
    "href": "http://stock.jrj.com.cn/2022/02/23191234447745.shtml",
    "datetime": "2022-02-23 19:12:08",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)业绩快报：2021年度净利润升10.33%至1.6亿元",
    "href": "http://stock.jrj.com.cn/2022/02/23154334447270.shtml",
    "datetime": "2022-02-23 15:43:05",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：年内累计获得政府补助1581.69万元",
    "href": "http://stock.jrj.com.cn/2021/12/27154034070199.shtml",
    "datetime": "2021-12-27 15:40:19",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：子公司原料药枸橼酸托法替布、替格瑞洛通过CDE审批",
    "href": "http://stock.jrj.com.cn/2021/12/10192433995692.shtml",
    "datetime": "2021-12-10 19:24:49",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：全资子公司3个原料药品种已通过药品GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2021/12/03162133960283.shtml",
    "datetime": "2021-12-03 16:21:11",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：拟出资2000万元参与设立产业投资基金",
    "href": "http://stock.jrj.com.cn/2021/11/08165033823549.shtml",
    "datetime": "2021-11-08 16:50:43",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：第三季度净利增长0.56%至3409.44万元",
    "href": "http://stock.jrj.com.cn/2021/10/27191233763435.shtml",
    "datetime": "2021-10-27 19:12:48",
    "code": "688799"
  },
  {
    "title": "华纳药厂上市3个月7500万身价董秘离职 副董事长徐燕或牵涉行贿案",
    "href": "http://stock.jrj.com.cn/2021/10/16113833701936.shtml",
    "datetime": "2021-10-16 11:38:00",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：恩替卡韦颗粒(0.5mg)生产批件申请审批完毕",
    "href": "http://stock.jrj.com.cn/2021/09/14160133434203.shtml",
    "datetime": "2021-09-14 16:01:06",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：子公司依地酸钙钠、铝镁加等4个原料药品种通过药品GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2021/09/13163133428595.shtml",
    "datetime": "2021-09-13 16:31:25",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：子公司原料药“盐酸西替利嗪”通过CDE审批",
    "href": "http://stock.jrj.com.cn/2021/09/06165433392517.shtml",
    "datetime": "2021-09-06 16:54:42",
    "code": "688799"
  },
  {
    "title": "华纳药厂2021年半年度净利6916.67万元 同比净利增加21.60%",
    "href": "http://stock.jrj.com.cn/2021/08/30115333350981.shtml",
    "datetime": "2021-08-30 11:53:32",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)半年度净利润6916.67万元 同比增长21.60%",
    "href": "http://stock.jrj.com.cn/2021/08/29174033340803.shtml",
    "datetime": "2021-08-29 17:40:45",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：拟向手性药物公司提供不超4300万元无息借款用于实施“药物研发项目”",
    "href": "http://stock.jrj.com.cn/2021/08/05211433209082.shtml",
    "datetime": "2021-08-05 21:14:09",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：拟以不超4.5亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/08/05154233206814.shtml",
    "datetime": "2021-08-05 15:42:39",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：拟使用不超4.5亿元暂时闲置自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/08/05154033206810.shtml",
    "datetime": "2021-08-05 15:40:50",
    "code": "688799"
  },
  {
    "title": "华纳药厂上市首日涨75% IPO募7.2亿西部证券赚0.5亿",
    "href": "http://stock.jrj.com.cn/2021/07/13152533089152.shtml",
    "datetime": "2021-07-13 15:25:00",
    "code": "688799"
  },
  {
    "title": "今日上市：中科通达、华纳药厂",
    "href": "http://stock.jrj.com.cn/2021/07/13085633087042.shtml",
    "datetime": "2021-07-13 08:56:00",
    "code": "688799"
  },
  {
    "title": "华纳药厂：将于7月13日在上海证券交易所科创板上市",
    "href": "http://stock.jrj.com.cn/2021/07/12102333081672.shtml",
    "datetime": "2021-07-12 10:23:10",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)将于7月13日上市",
    "href": "http://stock.jrj.com.cn/2021/07/11155233075426.shtml",
    "datetime": "2021-07-11 15:52:40",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)披露上市发行结果：遭弃购4791股 由主承销商包销",
    "href": "http://stock.jrj.com.cn/2021/07/06191133054173.shtml",
    "datetime": "2021-07-06 19:11:12",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：网上发行最终中签率为0.02687786%",
    "href": "http://stock.jrj.com.cn/2021/07/01190633028684.shtml",
    "datetime": "2021-07-01 19:06:06",
    "code": "688799"
  },
  {
    "title": "今日申购：中科通达、华纳药厂",
    "href": "http://stock.jrj.com.cn/2021/07/01090033026138.shtml",
    "datetime": "2021-07-01 09:00:00",
    "code": "688799"
  },
  {
    "title": "华纳药厂(688799.SH)：IPO定价30.82元/股 7月1日开启申购",
    "href": "http://stock.jrj.com.cn/2021/06/29192333017169.shtml",
    "datetime": "2021-06-29 19:23:19",
    "code": "688799"
  },
  {
    "title": "证监会同意艾为电子、倍轻松、华纳药厂、华依科技、天微电子科创板IPO注册",
    "href": "http://stock.jrj.com.cn/2021/06/08205632895667.shtml",
    "datetime": "2021-06-08 20:56:00",
    "code": "688799"
  },
  {
    "title": "研究 | 华纳药厂：独董供职竞争对手 募投项目“变脸”或夸大投资额",
    "href": "http://stock.jrj.com.cn/2021/03/03204132065522.shtml",
    "datetime": "2021-03-03 20:41:58",
    "code": "688799"
  },
  {
    "title": "西部证券两保代遭监管警示 保荐华纳药厂履职不到位",
    "href": "http://stock.jrj.com.cn/2021/01/28131931800639.shtml",
    "datetime": "2021-01-28 13:19:00",
    "code": "688799"
  },
  {
    "title": "尚沃医疗、华纳药厂、兴嘉生物IPO保荐等责任人遭监管警示，会否影响“登科”之路？",
    "href": "http://stock.jrj.com.cn/2021/01/28095731799865.shtml",
    "datetime": "2021-01-28 09:57:27",
    "code": "688799"
  },
  {
    "title": "华纳药厂药品不合规遭上海通报 科创板上市已过会",
    "href": "http://stock.jrj.com.cn/2021/01/07134431647353.shtml",
    "datetime": "2021-01-07 13:44:00",
    "code": "688799"
  },
  {
    "title": "华纳药厂日均9场会屡涉不合格 专利案两败募资超资产",
    "href": "http://stock.jrj.com.cn/2020/12/28071631583822.shtml",
    "datetime": "2020-12-28 07:16:00",
    "code": "688799"
  },
  {
    "title": "华纳药厂：今年科创板过会第202家 西部证券过6单",
    "href": "http://stock.jrj.com.cn/2020/12/16104231500535.shtml",
    "datetime": "2020-12-16 10:42:00",
    "code": "688799"
  },
  {
    "title": "华纳药厂IPO暴雷：产品不合格 专利有纠纷 财务现隐忧",
    "href": "http://stock.jrj.com.cn/2020/12/14081631484757.shtml",
    "datetime": "2020-12-14 08:16:00",
    "code": "688799"
  },
  {
    "title": "华纳药厂陷专利诉讼 销售费用猛增",
    "href": "http://stock.jrj.com.cn/2020/12/14042831481700.shtml",
    "datetime": "2020-12-14 04:28:39",
    "code": "688799"
  },
  {
    "title": "联测科技、华纳药厂12月15日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2020/12/04181231409529.shtml",
    "datetime": "2020-12-04 18:12:00",
    "code": "688799"
  },
  {
    "title": "市场推广费金额较大 2019年仿制药销售收入占比超50% 华纳药厂科创板IPO第二轮问询已回复 | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/10/23190831118047.shtml",
    "datetime": "2020-10-23 19:08:24",
    "code": "688799"
  },
  {
    "title": "带着官司转战科创板 华纳药厂IPO胜算几何",
    "href": "http://stock.jrj.com.cn/2020/09/10020130714315.shtml",
    "datetime": "2020-09-10 02:01:07",
    "code": "688799"
  }
]